Neuromuscular Monitoring Clinical Trial
Official title:
Clinical Practice Survey on the Management of Neuromuscular Blocking Agents and Their Antagonism During General Anesthesia
Neuromuscular blocking agents (NMBA) are commonly used in clinical practice during general anesthesia to facilitate induction, intubation and surgery. Some studies have shown that their use can be deleterious if not codified. Recent recommendations concerning their use and antagonization were published in 2023. Research hypothesis: Using a single-center, retrospective practice study, we aim to analyze whether the 2023 ASA and ESAIC recommendations are being implemented regarding the use of neuromuscular blocking agents.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02880787 -
Comparison of Two Neuromuscular Transmission Monitors Based on Acceleromyography: TOF-Watch SX® and TOFScan®
|
N/A | |
Completed |
NCT03804346 -
Infantile - Postoperative Residual Curarization - Study
|
||
Completed |
NCT02630576 -
Neurostimulation and Electromyographs Assessment of th TetraGraph in Healthy (Volunteers
|
N/A | |
Completed |
NCT02711917 -
Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane
|
N/A | |
Terminated |
NCT03778749 -
Electromyography and Acceleromyography in Ventilated ICU Patients
|
N/A | |
Completed |
NCT02350062 -
Comparison of Two Neuromuscular Monitors
|
N/A | |
Recruiting |
NCT03605225 -
Development and Validation of an Android-based Application for Anaesthesia Neuromuscular Monitoring
|
N/A | |
Completed |
NCT02025309 -
Intraoperative Methylprednisolone and Sugammadex
|
Phase 4 | |
Completed |
NCT04947306 -
A Comparison Between TOF Watch® SX and Tetragraph®
|